ArticleArthroplasty (London, England)2026
Dermatomyositis does not adversely affect functional outcomes after total hip arthroplasty: a 1:2 matched case-control study.
Article in Arthroplasty (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundPatients with dermatomyositis (DM) are predisposed to osteonecrosis of the femoral head (ONFH), frequently requiring total hip arthroplasty (THA). However, limited evidence exists regarding postoperative outcomes in this population. This study aimed to evaluate functional outcomes and complication rates after THA in patients with DM compared to a matched cohort of patients without DM.
methodsA retrospective case-control study was conducted using our institution's arthroplasty registry. We identified 18 patients (21 operations) with DM who underwent primary THA and matched them in a 1:2 ratio to 36 patients (42 operations) who underwent THA for hip osteoarthritis, alcohol-induced ONFH, or Crowe I-II developmental dysplasia of hips (DDH). Functional outcomes and health-related quality of life (QoL) were assessed, and postoperative complications were recorded.
resultsAt a mean follow-up of 4.87 years, both cohorts demonstrated comparable improvements in all functional and QoL measures (all postoperative comparisons, p > 0.05). The rate of complications, including dislocation, periprosthetic joint infection, and revision, was not significantly different between groups. However, respiratory complications occurred more frequently in the DM cohort (4/21 vs. 0/42, p = 0.010). Within the DM group, postoperative respiratory complications showed a preliminary association with higher preoperative D-dimer levels (p = 0.040).
conclusionsPatients with DM can achieve excellent functional outcomes after THA, comparable to those of patients without rheumatic autoimmune disease. Although most complication rates are similar, DM patients have an elevated risk of postoperative respiratory complications. Preoperative assessment of D-dimer levels and pulmonary function, along with proactive postoperative respiratory rehabilitation, may help reduce this risk in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.